Test Price
2,800 AED✅ Home Collection Available
ATP1A3 Gene (DYT12) Sequencing Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATP1A3 DYT12 بتقنية التسلسل الجيني من الجيل التالي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
فحص جيني دقيق لتحديد الطفرات في جين ATP1A3 المرتبط بخلل التوتر العضلي الأولي DYT12 ومتلازمة الشلل النصفي التبادلي عند الأطفال. معتمد من هيئة الصحة بدبي وفق أحدث إرشادات 2026.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Result Interpretation by genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Facility License: 9834453
ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
Turnaround Time: 3 – 4 Weeks
Sample Options: Whole Blood (EDTA/DNA FTA Card) or Extracted DNA
Price: 2800 AED (all-inclusive)
Test Overview & Clinical Utility
The ATP1A3 NGS test sequences the entire coding region of the gene associated with DYT12 dystonia and alternating hemiplegia of childhood (AHC). This advanced next‑generation sequencing (NGS) technology replaces older single‑exon methods with 99.9% coverage uniformity, delivering a molecular diagnosis in 3–4 weeks.
تحليل جين ATP1A3 بتقنية NGS هو المعيار الذهبي لتشخيص خلل التوتر DYT12. يستخدم اختبارنا أحدث أجهزة التسلسل لتغطية جميع الإكسونات بدقة عالية.
| Feature | Our Test (NGS – UAE DHA Certified) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity & specificity – full gene coverage | ~90% for targeted hotspots, may miss deep intronic variants |
| Methodology | LC‑MS/MS validated NGS (Illumina NovaSeq) | Capillary electrophoresis (Sanger) |
| Turnaround | 3–4 weeks | 6–8 weeks (often outsourced) |
| Cost | 2800 AED – includes post‑test counselling | ~3500 AED (excl. interpretation) |
| Regulatory | ISO 9001:2015, DHA 2026 compliant, UAE PDPL | Variable |
Physician Insight & Safety Protocol
"As a DHA‑licensed neurologist, I want to emphasize that a positive ATP1A3 result does not automatically dictate the clinical course; many carriers remain asymptomatic. Correlation with detailed neurological examination, family history, and functional outcomes is essential. Never stop or adjust prescribed medication, especially anti‑dystonia agents like trihexyphenidyl or benzodiazepines, without direct specialist consultation."
— Dr. PRABHAKAR REDDY, DHA License #61713011, Consultant Neurologist & Clinical Geneticist
🚨 Important Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of dopamine‑modulating drugs or muscle relaxants can trigger severe dystonic crisis or autonomic instability.
Exclusion Criteria & ER Red Flags
Exclusion Criteria:
- Inability to provide informed consent (or legal guardian consent for minors per CDS Law 2026).
- Patients currently undergoing intensive plasmapheresis that may interfere with DNA integrity.
- Known coagulopathy unrelated to the condition under investigation.
Seek Emergency Care if you experience:
- Sudden severe generalized dystonia (“status dystonicus”)
- Autonomic instability: respiratory compromise, labile blood pressure, or hyperthermia
- Loss of ambulation or acute swallowing difficulty
This test is not a standalone diagnostic tool. Always follow the genetic counselling session and a comprehensive clinical assessment.
Frequently Asked Questions
What is the ATP1A3 gene test, and why might I need it?
This identifies pathogenic variants in the ATP1A3 gene that cause DYT12 dystonia or alternating hemiplegia of childhood (AHC), enabling accurate diagnosis and family counselling.
يكشف هذا الفحص عن الطفرات المسببة للأمراض في جين ATP1A3 المسؤول عن خلل التوتر DYT12 أو الشلل النصفي التبادلي عند الأطفال، مما يتيح التشخيص الدقيق والاستشارة الوراثية العائلية.
How is the sample collected, and is a hospital visit required?
A certified phlebotomist performs a standard blood draw from your arm; alternatively, a fingerprick DNA FTA card can be used – all through DHA‑approved home collection service, avoiding any hospital visit.
يقوم فني مختص بسحب عينة دم من الوريد في المنزل عبر خدمة الجمع المنزلي المعتمدة من هيئة الصحة بدبي، أو باستخدام بطاقة FTA لبصمة دم من الإصبع دون الحاجة لزيارة المستشفى.
Will my insurance cover the 2800 AED cost? What about data privacy?
We offer direct billing verification with all major UAE insurers; send your insurance card via WhatsApp to +971 54 548 8731 for instant coverage confirmation. All genetic data is secured under UAE PDPL and Federal Decree‑Law No. 41 of 2024 (Art. 87).
نتيح التحقق المباشر من التغطية التأمينية عبر واتساب على الرقم +971 54 548 8731. جميع البيانات الجينية محمية بموجب قانون حماية البيانات الشخصية (PDPL) والمرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87).
📞 WhatsApp / Call: +971 54 548 8731 | DHA Lab License: 9834453 | ISO 9001:2015 (INT/EGQ/2509DA/3139)
© 2026 – All rights reserved. Compliant with UAE Ministry of Health & Prevention and DHA standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians